These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 197499)

  • 21. Accumulation of 99mTc-diphosphonate in four patients with hepatic neoplasm: case reports.
    Guiberteau MJ; Potsaid MS; McKusick KA
    J Nucl Med; 1976 Dec; 17(12):1060-1. PubMed ID: 186568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
    Büll U; Pfeifer JP; Niendorf HP; Tongendorff J
    Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What causes lower neck uptake in bone scans?
    Oppenheim BE; Cantez S
    Radiology; 1977 Sep; 124(3):749-52. PubMed ID: 196313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant differences amont the 99mTc-polyphosphates, 99mTc-pyrophosphates, and 99mTc-diphosphonates for bone imaging.
    Weber DA; Keyes JW; Wilson GA
    CRC Crit Rev Clin Radiol Nucl Med; 1977 Jan; 8(4):369-90. PubMed ID: 189966
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value and limitations of scintiscanning with strontium 85 in diagnosis of bone diseases].
    Panicucci F; Buia L
    Riv Crit Clin Med; 1968; 68(4):324-39. PubMed ID: 5746287
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative investigations concerning osteotropic radiopharmaceuticals. III. Scanning with 18F and 99mTc-malignant diseases (author's transl)].
    Creutzig H
    Rofo; 1975 Nov; 123(5):462-7. PubMed ID: 128507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radionuclide bone scanning in diseases of the spine.
    Patton DD; Woolfenden JM
    Radiol Clin North Am; 1977 Aug; 15(2):177-201. PubMed ID: 267956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [99mTc-polyphosphate scintigraphy of joints, xeroradiography and radiography of hands].
    Hermann HJ; Kraska H; Falck I; Sörensen H; Soulier W
    Nucl Med (Stuttg); 1975 Jan; 13(4):341-54. PubMed ID: 1078726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 24-Hour/4-hour ratio of technetium-99m methylene diphosphonate uptake in patients with bone metastases and degenerative bone changes.
    Israel O; Front D; Frenkel A; Kleinhaus U
    J Nucl Med; 1985 Mar; 26(3):237-40. PubMed ID: 3156220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
    Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
    Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized skeletal response to 99mtechnetium methylene diphosphonate in rheumatoid arthritis.
    Helfgott S; Rosenthall L; Esdaile J; Tannenbaum H
    J Rheumatol; 1982; 9(6):939-41. PubMed ID: 6219221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 18F and 99mTc-polyphosphate in orthopedic bone scintigraphy.
    Heerfordt J; Vistisen L; Bohr H
    J Nucl Med; 1976 Feb; 17(02):98-103. PubMed ID: 173816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone scan patterns of patients with diffuse metastatic carcinoma of the axial skeleton.
    Witherspoon LR; Blonde L; Shuler SE; McBurney DB
    J Nucl Med; 1976 Apr; 17(4):253-7. PubMed ID: 176333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumors.
    Citrin DL; Bessent RG; McGinley E; Gordon D
    J Nucl Med; 1975 Oct; 16(10):886-90. PubMed ID: 809552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 99mTc-polyphosphate and 18F. II. Imaging.
    Krishnamurthy GT; Walsh CF; Shoop LE; Berger HG; Blahd WH
    J Nucl Med; 1974 Oct; 15(10):837-43. PubMed ID: 4417868
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Comparison of 99Tc-labelled polyphosphate, pyrophosphate and ethane hydroxydiphosphonate in patients with skeletal metastases.
    Citrin DL; Bessent RG; Tuohy JB; Elms ST; McGinlay E; Greig WR; Blumgart LH
    Br J Surg; 1974 Apr; 61(4):330. PubMed ID: 4364998
    [No Abstract]   [Full Text] [Related]  

  • 37. [99mTc-labeled sodium pyrophosphate in the study of primary and secondary bone cancer].
    Ducassou D; Leccia F; Pigneux J; Blanquet P
    Strahlentherapie Sonderb; 1975; 74():346-56. PubMed ID: 173050
    [No Abstract]   [Full Text] [Related]  

  • 38. [99m Tc Sn-pyrophosphate complex as a bone gammography agent in children].
    Avila Ramírez E; Goldberg de Liverant J; Larrondo JJ
    Bol Med Hosp Infant Mex; 1974; 31(6):1115-24. PubMed ID: 4373020
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J; Montz R
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
    Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
    J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.